A new rapid blood test for HIV, Hepatitis B, and Hepatitis C
Part of Digestive system, Infections clinical trials.
This trial tests a new rapid blood test (called MaGIA IBC) that checks for HIV, Hepatitis B, and Hepatitis C all at once. It's for people who already know or might have one of these infections. Participating helps see if this test works well in real-world settings.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must either know you have HIV, know you have Hepatitis B, or know or suspect you have Hepatitis C (with a positive rapid test result).
- You must agree to take part in the study.
- You must have health insurance or be part of an outdoor testing campaign.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study evaluates a new blood test that checks for HIV, hepatitis B, hepatitis C, and syphilis all at once. It is designed to see how well the test works in different groups of people, including those with known infections and those without.
This study is testing a quick, point-of-care test that checks for HIV, hepatitis B and C, and syphilis in pregnant women in the DR Congo. The goal is to see if the test works well so that more women can get screened and treated early, protecting both mother and baby.
This study evaluates a new rapid blood test that checks for HIV, hepatitis B, and syphilis all at once. Researchers want to make sure the test works well, is easy to use, and gives accurate results.
This study evaluates a new fingerstick blood test that can quickly check for HIV, hepatitis B, and syphilis. You'll provide small blood samples and help researchers understand how well the test works and how easy it is to use.
This trial studies point-of-care (on-site) testing to find hepatitis C in adults who are at higher risk. If hepatitis C is found, earlier detection can help you get connected to care sooner.
This study is testing a tool to find people who may be at risk for or already have HIV or hepatitis C. It aims to connect them with care and support.
Hear when a new Combined Point of Care Diagnostic of HIV, HBV and HCV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.